La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

TalkMed Group Gestione

Gestione criteri di controllo 1/4

TalkMed Group's Il CEO è Peng Tiam Ang, nominato in Sep2013, ha un mandato di 10.92 anni. possiede direttamente 64.74% delle azioni della società, per un valore di SGD 330.68M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 9.9 anni e 2.8 anni.

Informazioni chiave

Peng Tiam Ang

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	10.9yrs
Proprietà del CEO	64.7%
Durata media del management	9.9yrs
Durata media del Consiglio di amministrazione	2.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Apr 08

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Mar 01

AMMINISTRATORE DELEGATO

Peng Tiam Ang (65 yo)

10.9yrs

Mandato

Dr. Peng Tiam Ang has been the Chief Executive Officer of TalkMed Group Limited since September 10, 2013. Dr. Ang provides the vision and the strategic direction for TalkMed Group. He serves as Medical Dir...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Peng Tiam Ang	CEO & Executive Director	10.9yrs	Nessun dato	64.74% SGD 343.6m
Boon Yong Lee	Group CFO & Joint Company Secretary	9.9yrs	Nessun dato	Nessun dato
Kei Siong Khoo	Chief Operating Officer	10.9yrs	Nessun dato	7.49% SGD 39.7m
Heng Chong Lim	Joint Company Secretary	8.8yrs	Nessun dato	Nessun dato
Jacqueline Anne Low	Joint Company Secretary	2.9yrs	Nessun dato	Nessun dato

9.9yrs

Durata media

Gestione esperta: Il team dirigenziale di 5G3 è esperto e expertise (durata media dell'incarico 9.9 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Peng Tiam Ang	CEO & Executive Director	10.9yrs	Nessun dato	64.74% SGD 343.6m
Kei Siong Khoo	Chief Operating Officer	no data	Nessun dato	7.49% SGD 39.7m
Yih Pin Sitoh	Non-Independent Non-Executive Director	10.7yrs	Nessun dato	Nessun dato
S. Chandra Rajagopal Sitaram Das	Non-Independent Non-Executive Chairman	10.7yrs	Nessun dato	0.083% SGD 440.1k
Swee Yam Sim	Independent Non-Executive Director	less than a year	Nessun dato	Nessun dato
Ching Ching Leong	Independent Non-Executive Director	2.8yrs	Nessun dato	0.023% SGD 120.0k
Khai Tong Tan	Independent Non-Executive Director	less than a year	Nessun dato	0.0045% SGD 24.0k
Kok Shang Lam	Independent Non-Executive Director	less than a year	Nessun dato	Nessun dato

2.8yrs

Durata media

63.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 5G3 non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.

TalkMed Group Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

TalkMed Group Limited, Annual General Meeting, Apr 18, 2024

TalkMed Group Limited Announces Management Changes

TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024

Insufficient new directors

Insufficient new directors

Insufficient new directors

Recent updates

Upcoming dividend of S$0.023 per share

First half 2024 earnings released: EPS: S$0.006 (vs S$0.009 in 1H 2023)

First half dividend of S$0.023 announced

Upcoming dividend of S$0.013 per share

TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Final dividend reduced to S$0.013

TalkMed Group Limited, Annual General Meeting, Apr 18, 2024

Full year 2023 earnings released

Talkmed Group Limited Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2023, Payable on 10 May 2024

TalkMed Group Limited Announces Management Changes

TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024

First half 2023 earnings released: EPS: S$0.011 (vs S$0.009 in 1H 2022)

TalkMed Group Limited Approves the Final One-Tier Tax-Exempt Dividend in Respect of 2022

Upcoming dividend of S$0.015 per share at 7.0% yield

Full year 2022 earnings released: EPS: S$0.023 (vs S$0.019 in FY 2021)

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Full year 2022 earnings released

Insufficient new directors

TalkMed Group Limited Announces Tax Exempt (One-Tier) Interim Cash Dividend, Payable on 22 August 2022

First half 2022 earnings released

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

TalkMed Group Limited, Annual General Meeting, Apr 21, 2022

Insufficient new directors

Full year 2021 earnings: Revenues exceed analyst expectations

TalkMed Group Limited Proposes Final Dividend, Payable on 11 May 2022

Joint Company Secretary Lingna Dai has left the company

New 90-day low: S$0.40

TalkMed Group Limited, Annual General Meeting, Apr 20, 2021

Full year 2020 earnings released

Revenue beats expectations, earnings disappoint

New 90-day high: S$0.46

New 90-day low: S$0.38

First half earnings released

New 90-day low - S$0.38

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media